Adagio Medical Inc. (ADGM)
NASDAQ: ADGM
· Real-Time Price · USD
1.28
0.02 (1.19%)
At close: Aug 15, 2025, 3:49 PM
Adagio Medical Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
Revenue | n/a | -143K | 132K | 254K | 26K | 78K | 41K | n/a | 60K | n/a |
Cost of Revenue | 253K | 299K | 414K | 682K | 542K | 334K | 253K | n/a | 318K | 291K |
Gross Profit | -253K | -442K | -386K | -428K | -516K | -256K | -212K | n/a | -258K | -291K |
Operating Income | -7.4M | -50.78M | -4.42M | -6.66M | -611.74K | -2.75M | -9.08M | -78.85K | -968.6K | -6.21M |
Interest Income | 164K | n/a | n/a | n/a | 1K | 1K | n/a | 460.36K | 1K | 4K |
Pretax Income | -7.71M | -50.66M | 3.61M | -6.46M | -245.85K | -2.22M | -10.76M | 381.51K | 160.25K | -6.03M |
Net Income | -7.71M | -52.8M | n/a | -713.79K | -245.85K | -2.22M | -10.76M | 381.51K | 160.25K | -6.03M |
Selling & General & Admin | 3.48M | 2.79M | 2.93M | 6.23M | 611.74K | 2.75M | 4.45M | 78.85K | 968.6K | 1.46M |
Research & Development | 3.66M | 3.42M | 1.22M | 2.87M | 3.47M | 1.77M | 4.42M | n/a | 4.8M | 4.45M |
Other Expenses | n/a | 44.66M | n/a | n/a | -145.86K | 93K | n/a | n/a | 4K | n/a |
Operating Expenses | 7.14M | 50.37M | 4.14M | 6.23M | 611.74K | 2.75M | 8.87M | 78.85K | 968.6K | 5.92M |
Interest Expense | 662K | n/a | n/a | n/a | 754K | 577K | 485K | n/a | 233K | 137K |
Selling & Marketing Expenses | n/a | 2.18M | n/a | n/a | n/a | n/a | 3.49M | n/a | n/a | n/a |
Cost & Expenses | 7.4M | 50.67M | 4.56M | 6.91M | 611.74K | 2.75M | 9.12M | 78.85K | 968.6K | 6.21M |
Income Tax Expense | n/a | 9.12M | n/a | -8.28M | -841.75K | -133K | n/a | n/a | -124K | n/a |
Shares Outstanding (Basic) | 15.38M | 14.87M | 14.54M | 7.66M | 7.78M | 7.93M | 13.39M | 7.43M | 15.06M | 19.19M |
Shares Outstanding (Diluted) | 15.38M | 14.87M | 14.54M | 7.66M | 7.78M | 7.93M | 13.39M | 7.43M | 15.06M | 19.19M |
EPS (Basic) | -0.5 | -3.55 | n/a | -0.09 | -0.03 | -0.28 | -0.8 | 0.05 | 0.01 | -0.31 |
EPS (Diluted) | -0.51 | -3.55 | n/a | -0.09 | -0.03 | -0.28 | -0.8 | 0.05 | 0.01 | -0.31 |
EBITDA | -7.4M | -56.27M | -3.63M | -6.4M | -8.48M | -2.75M | -10.28M | -78.85K | -6.53M | -5.76M |
EBIT | n/a | -56.7M | -3.89M | -6.66M | -7.26M | -8.56M | -9.08M | n/a | -9.04M | -5.89M |
Depreciation & Amortization | n/a | 424K | n/a | 257K | 330K | 133K | n/a | n/a | 124K | 135K |